Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Apyx Medical ( (APYX) ) is now available.
On August 7, 2025, Apyx Medical Corporation held its Annual Meeting of Stockholders, where stockholders approved an amendment to the company’s Certificate of Incorporation. This amendment involved the removal of Article EIGHTH, which was replaced with ‘intentionally omitted.’ Subsequently, on December 8, 2025, the company filed a Certificate of Amendment with the Secretary of State of Delaware to implement this change.
The most recent analyst rating on (APYX) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Apyx Medical stock, see the APYX Stock Forecast page.
Spark’s Take on APYX Stock
According to Spark, TipRanks’ AI Analyst, APYX is a Neutral.
Apyx Medical’s overall stock score reflects a mix of financial challenges and positive market momentum. The company’s strong technical indicators and successful product launch are significant strengths, while ongoing financial losses and valuation concerns weigh on the score. The recent capital raise is a positive development, potentially improving financial stability.
To see Spark’s full report on APYX stock, click here.
More about Apyx Medical
Average Trading Volume: 123,139
Technical Sentiment Signal: Hold
Current Market Cap: $165.3M
For a thorough assessment of APYX stock, go to TipRanks’ Stock Analysis page.